by Aaron Conley, Vanderbilt University Credit: Unsplash/CC0 Public Domain Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. The research was led by Lisa Monteggia, professor of pharmacology and director of the Vanderbilt...
